Best of ASCO - 2014 Annual Meeting

 

Welcome

Biomarkers/Epidemiology/Outcomes

Head and Neck Cancer

2019 ASCO Annual Meeting

Sort by: title abstract no. first author
ABSTRACT TITLEFIRST AUTHORABSTRACT NO.
A novel mechanism of miRNA-mediated CBX8 associated with tumorigenesis in head and neck squamous cell carcinoma.

Shine-Gwo Shiah

e17534

A phase II randomized control trial of erlotinib in combination with celecoxib in patients with operable oral squamous cell carcinoma (OSCC): Erlo-Xib Study.

Sudhir Vasudevan Nair

6054

Analysis of race and gender disparities in mortality trends from patients diagnosed with nasopharyngeal, oropharyngeal and hypopharyngeal cancer from 2000 to 2014.

Kristine Badin

e17533

Association between human papillomavirus (HPV) status and duration of response of anti-programmed cell death protein-1 (PD-1) inhibitors in patients with recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC).

Kedar Kirtane

6044

Association of low neutrophil-to-lymphocyte ratios (NLR) and high lymphocyte-to-monocyte ratios (LMR) with overall survival and response to induction chemotherapy (IC) when used to select patients (pts) with locally advanced squamous cell of the larynx (LSCC) for combined chemoradiation (CRT).

Zachary Risch

e17539

Association of single nucleotide polymorphisms within genes in NF-κB, TGF-β, and JNK signaling pathways with the risks of nasopharyngeal carcinoma in Chinese Han.

Hanyi Zhang

6053

Associations between pretreatment body mass index and presence of post-treatment nutrition impact symptoms in head and neck cancer survivors.

Katherine G. Douglas

e17547

Biomarker predictors of outcome from a randomized trial of nivolumab +/- stereotactic body radiotherapy (SBRT) in metastatic (M1) head and neck squamous cell carcinoma (HNSCC).

Sean Matthew McBride

6063

Biomarkers of resistance to cetuximab in head and neck squamous cell carcinoma (HNSCC).

Ekaterina I. Surikova

e17523

Changes in KRAS mutations in patients with oral mucosa and tongue cancer (OMTC) undergoing medical treatment with cetuximab (Cet).

Aza A. Lyanova

e17524

Changes in the proportion of squamous cell carcinoma in head and neck cancer in the United States and Canada, 1995-2015.

Matthew Gaubatz

e17554

Clinical prognostic factors in patients with recurrent or metastatic carcinoma of the head and neck treated with immune checkpoints therapies.

Carlo Resteghini

e17530

Comparison of the seventh and eighth editions of the American Joint Committee on Cancer (AJCC) staging for oropharyngeal squamous cell carcinomas (OPSCC): A Surveillance, Epidemiology and End Results Program (SEER) database analysis.

Sumita Trivedi

e17538

Connective tissue growth factor (CTGF) methylation status is associated with prognosis of patients with head and neck squamous cell carcinoma (HNSCC) treated with radiochemotherapy (RCHT): A multicenter study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).

Bouchra Tawk

6050

Correlation of angiogenic and immunomodulatory proteins with clinical outcomes of durvalumab (anti-PDL1) in recurrent/metastatic head and neck squamous cell carcinoma.

Xiang Guo

6048

COX-2 expression and mesenchymal-transition status on circulating tumor cells to predict survival in patients with nasopharyngeal carcinoma: A prospective analysis.

Yongjiang Li

6042

Cumulative odds of increased comorbid score in head and neck cancer.

Katherine M. Polednik

e17555

Depth of invasion in early oral cancers: Is it an independent prognostic factor?

Harsh Dhar

6058

Determining the biomarker landscape and its impact on outcomes in HPV+ head and neck cancer after primary resection.

Suchin Rajeev Khanna

e17520

Development of a clinicomolecular risk stratification system for nonmetastatic nasopharyngeal carcinoma using Epstein–Barr virus DNA and TNM stage: A “Big data” analysis of 9,160 endemic cases.

Fo-Ping Chen

6043

Discordant treatment response in primary tumors and lymph node metastases after four weeks of preoperative PD-1 blockade in head and neck squamous cell carcinoma (HNSCC).

Adam Luginbuhl

6016

Evaluating sociodemographic, behavioral and psychologic disparities in 918 head and neck cancer survivors.

Andrew T Day

e17541

Evolutionary action score of TP53 analysis in pathologically high-risk HPV-negative head and neck cancer from a phase II clinical trial: NRG Oncology RTOG 0234.

Chieko Michikawa

6010

Genome-wide study of salivary microRNAs as potential noninvasive biomarkers for detection of nasopharyngeal carcinoma.

Lirong Wu

e17535

Genomic and transcriptomic landscape of oral pre-cancers (OPCs) and risk of oral cancer (OC).

William Nassib William

6009

Identifying adverse molecular features of HPV+ head and neck cancers using patient-derived models.

Devraj Basu

6057

Immune signatures associated with response to neoadjuvant PD-1 blockade in oral cavity cancer.

Hannah Knochelmann

6055

Impact of adjuvant chemotherapy and cumulative cisplatin dose in locally advanced nasopharyngeal carcinoma (LA-NPC) treated with definitive chemoradiotherapy.

Marc Oliva Bernal

6046

Impact of reactive gastrostomy tube placement on clinical course of oropharynx cancer patients treated with chemoradiation.

Ami A Dave

e17540

Impact of tobacco smoking on radiotherapy outcomes in 1875 HPV-positive oropharynx cancer patients.

Pernille Lassen

6047

Longitudinal circulating Epstein–Barr virus DNA response to induction chemotherapy and chemo-radiotherapy to identify biological phenotypes in EBV-associated nasopharynx of head and neck cancer.

Jia-Wei Lv

6021

Multiplexed digital PCR for detection of HPV in tissue samples from oropharyngeal cancer patients.

Sunil Kumar

e17552

Mutational profile of dysplastic lesions evolving to laryngeal cancer.

Santiago Cabezas-Camarero

e17551

Nationwide treatment patterns of oropharyngeal cancer in the human papillomavirus era.

Kailin Yang

e17521

Osimertinib and dihydroartemisinin: A novel drug combination targeting head and neck squamous cell carcinoma.

Rafael Rosell

e17526

PDL-1 expression in oral squamous cell carcinoma and implications for treatment.

Vijay Kumar Srinivasalu

e17527

Phase 1b study of chemoprevention with green tea polyphenon E (PPE) and epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (Erlotinib) in patients (pts) with advanced premalignant (AP) lesions of the head and neck.

Dong Moon Shin

6049

Predictive biomarkers for response to nivolumab in head and neck squamous cell carcinoma (HNSCC) (NCT#03652142).

Amanda Psyrri

6060

Predictive score for recurrence after complete resection in locally advanced oral cavity squamous cell carcinoma.

Hsueh-Ju Lu

e17536

Pretreatment obesity prolongs survival in elderly patients (≥65 years) with head and neck cancer (HNC).

Parth Anil Desai

6052

Prognostic impact of baseline circulating tumor cells (CTCs) detected by the isolation by size of epithelial tumor cells (ISET) in locally advanced head and neck squamous cell carcinoma (LAHNSCC): Results of a prospective study.

Thiago Bueno Oliveira

6061

Prognostic neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in locally advanced oropharyngeal cancer: a retrospective experience of two institutions.

Vittoria G. Espeli

e17548

Prophylactic gabapentin decreases fatigue and swallowing difficulty in patients undergoing concurrent chemo-radiation (CCR) for head and neck cancer (HNC): Interim results from a randomized controlled trial.

Barbara A. Murphy

6059

Racial disparities in outcome among head and neck cancer patients in the United States: An analysis using SEER-Medicare linked database.

Ikumi Suzuki

6051

Retrospective analysis of baseline clinical factors associated to CDDP-nephrotoxicity in locally advanced head and neck cancer (LAHNC) patients.

Francesca Platini

e17537

Risk of mortality varies by type of fat consumed in a longitudinal cohort of head and neck cancer patients.

Hania M. Taha

6056

Risk of second primary neoplasia in patients with oropharyngeal carcinoma: Role of HPV status in the outcome.

Antonio Lopez-Pousa

e17544

Role of the oral and gut microbiota as a biomarker in locoregionally advanced oropharyngeal squamous cell carcinoma (ROMA LA-OPSCC).

Marc Oliva Bernal

6045

Selected molecular markers as indicators of clinical profile, tumor characteristics and treatment outcome in squamous cell carcinoma of the larynx.

Elizabeth Mathew Iype

e17522

Survival estimates for young patients with tongue cancer: An analysis of the SEER database.

Pooja Khullar

e17549

TCGA data reveal a transcriptomic signature of Sox2 and Nanog targets associated with survival in head and neck cancer.

Nikol Mladkova

e17546

Translating transcriptome to immunophenotype in head and neck squamous cell carcinoma (HNSCC) to identify pathways promoting T-cell infiltration.

Theodoros Rampias

e17542

TREM-1 expression in HPV-related oropharyngeal squamous cell carcinoma.

Mario Airoldi

e17545

Tumor volume, circulating tumor cells, and cfDNA changes during radiotherapy in patients with head and neck cancer.

Sweet Ping Ng

6062

Upstaging of head and neck cancers due to extranodal extension: An Indian study.

Deepa M. Joseph

e17553